View Post

Which Studies Will be Practice Changing in Metastatic Breast Cancer?

In In The News by Barbara Jacoby

By: Greg Lau From: medpagetoday.com Promising findings from various clinical trials at the San Antonio Breast Cancer Symposiumopens in a new tab or window (SABCS) have the metastatic breast cancer research community excited about the future of treatment. In this exclusive MedPage Today video, Jason Aboudi Mouabbi, MD, assistant professor in the Department of Breast Medical Oncology at the University …

View Post

SABCS Trials Show Improved Outcomes in Metastatic Breast Cancer

In In The News by Barbara Jacoby

By: Greg Laub From: medpagetoday.com Oral selective estrogen receptor downregulators, or SERDs as they’re known, have now come into the market and are coming out of trials, I should say, and are being tested in phase II and now in phase III trials. The first one to report mature data from the phase III trial was elacestrant [Orserdu], which was …

View Post

Breast-conserving therapy may be viable option for multiple ipsilateral breast cancer

In In The News by Barbara Jacoby

From: healio.com Lumpectomy followed by radiation therapy resulted in low rates of local recurrence at 5 years among women with multiple ipsilateral breast cancer, according to phase 2 study results. The findings — presented at San Antonio Breast Cancer Symposium — also indicated women with two or more malignant lesions in the same breast considering breast-conserving therapy may benefit from …